Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Brewer; George J.
Address:
Ann Arbor, MI
No. of patents:
11
Patents:












Patent Number Title Of Patent Date Issued
7888389 Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies February 15, 2011
Disclosed are copper-binding compounds with improved properties and methods of using such compounds in the prevention and treatment of angiogenic diseases, such as cancer. Advantages of the invention include the enhanced stability of the compounds, which is achieved without reduction
7758898 Copper lowering treatment of inflammatory and fibrotic diseases July 20, 2010
The present invention relates generally to the field of prophylaxis and therapy for inflammatory and/or fibrotic diseases which include responses to injuries. In particular, the present invention is related to agents that can bind or complex copper such as thiomolybdate, and to the use o
7438931 Methods and compositions for the treatment of angiogenic diseases October 21, 2008
Provided are agents that can bind to copper, and form a tripartite complex with protein, and the use of these agents in the prevention and treatment of diseases with a vascular component, such as solid tumors. Compositions and methods for combination therapy of these diseases, including
7416741 Copper lowering treatment of inflammatory and fibrotic diseases August 26, 2008
The present invention relates generally to the field of prophylaxis and therapy for inflammatory and/or fibrotic diseases which include responses to injuries. In particular, the present invention is related to agents that can bind or complex copper such as thiomolybdate, and to the use o
6855340 Copper lowering treatment of inflammatory and fibrotic diseases February 15, 2005
The present invention relates generally to the field of prophylaxis and therapy for inflammatory and/or fibrotic diseases which include responses to injuries. In particular, the present invention is related to agents that can bind or complex copper such as thiomolybdate, and to the use o
6780583 DNA encoding canine von willebrand factor and methods of use August 24, 2004
The complete sequence of the canine von Willebrand Factor cDNA and deduced amino acid sequence is provided. The mutation which causes von Willebrand's Disease in Scottish Terriers, Doberman pinschers, Shetland sheepdogs, Manchester terriers and Poodles are also provided. Methods for
6767707 DNA encoding canine von willebrand factor and methods of use July 27, 2004
The complete sequence of the canine von Willebrand Factor cDNA and deduced amino acid sequence is provided. The mutation which causes von Willebrand's Disease in Scottish Terriers, Doberman pinschers, Shetland sheepdogs, Manchester terriers and Poodles are also provided. Methods for
6703050 Methods and compositions for the prevention or treatment of cancer March 9, 2004
Provided are agents that can bind to copper, and form a tripartite complex with protein, and the use of these agents in the prevention and treatment of diseases with a vascular component, such as solid tumors. Compositions and methods for combination therapy of these diseases, including
6410237 DNA encoding canine von Willebrand factor and methods of use June 25, 2002
The complete sequence of the canine von Willebrand Factor cDNA and deduced amino acid sequence is provided. The mutation which causes von Willebrand's Disease in Scottish Terriers, a single base deletion in exon 4, has also been determined. Methods for detecting carriers of the defec
6074832 DNA encoding canine von Willebrand factor and methods of use June 13, 2000
The complete sequence of the canine von Willebrand Factor cDNA and deduced amino acid sequence is provided. The mutation which causes von Willebrand's Disease in Scottish Terriers, Doberman pinschers, Shetland sheepdogs, Manchester terriers and Poodles are also provided. Methods for
6040143 DNA encoding von Willebrand factor and methods of use March 21, 2000
The complete sequence of the canine von Willebrand Factor cDNA and deduced amino acid sequence is provided. The mutation which causes von Willebrand's Disease in Scottish Terriers, a single base deletion in exon 4, has also been determined. Methods for detecting carriers of the defec










 
 
  Recently Added Patents
Subpixel-based image down-sampling
Printing device, printing system, program, and printing method for printing based on print data from a user authorized to issue a print instruction for the print data
Polyolefin and composition for pipe systems and sheets
System and method to obtain signal acquisition assistance data
Grid computing accounting and statistics management system
Luminaire
DKK1 oncogene as therapeutic target for cancer and a diagnosing marker
  Randomly Featured Patents
CVD diamond radiation detector
Cooler
Method and apparatus for initiation of servicing operations in a textile spinning machine
Fused bicyclic amide compounds and medicinal use thereof
Apparatus for measuring the wavelength, optical power and optical signal-to-noise ratio of each optical signal in wavelength-division multiplexing optical communication
Beverage compositions for human consumption
Apparatus for recording and/or reproducing digital data
Superscalar processor with plural pipelined execution units each unit selectively having both normal and debug modes
Fuel injected engine with cross scavenging
Apparatus and method for providing multimedia broadcast/multicast service in mobile communication system